Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

Galaxy Surfactants - EBITDA/kg has an upside risk - ICICI Securities

Posted On: 2020-11-23 05:25:53 (Time Zone: Arizona, USA)

Galaxy Surfactants' gross profit/kg may grow at 2.3% CAGR over FY21-23E to Rs40.6 (6.2% CAGR over FY18-20) on rise in new-age ingredients. EBITDA/kg may rise at 6.3% CAGR to Rs19.6 during the same period (6.3% CAGR over FY18-20). However, H1FY21 performance indicates significant upside risk to our estimates as it has achieved EBITDA/kg of Rs18.4. Our estimates factor EBITDA and net profit growth of 16.6% and 19.4% CAGR, respectively, over FY21-23E, and ROIC reach to 22.4% (up 310bps since FY20) by FY23E. We believe Galaxy's valuations are reasonable at 22xFY22E and 19xFY23E EPS. We raise our target price to Rs2,298 (from Rs2,133) as we rollover our valuations to Sep'22. Maintain BUY.

- What is driving higher gross profit/kg and EBITDA/kg for Galaxy? Galaxy has seen its gross profit/kg and EBITDA/kg rise by 4.1% and 12.1% in H1FY21 (YoY) to Rs40.8 and Rs18.4, respectively. Many investors remain suspicious on improvement in profitability, which they believe may have benefited from higher lauryl alcohol prices. The company has denied any benefit from higher lauryl alcohol prices to gross profit. Nonetheless, we have analysed the sensitivity of the movement in lauryl alcohol prices to gross profit/kg since FY13; and we have not seen any relationship as verified by the company. Moreover, large FMCG companies are well-informed customers. These companies are unlikely to allow Galaxy make any transitional profit while they fight cost inflation.

The analysis of specialty care contribution and gross profit/kg has shown strong relationship during the same period. During FY15-19, 100bps rise in specialty care contribution has added Rs0.8 to gross profit/kg and vice-a-versa. But in the past 18 months, gross profit/kg has improved despite fall in specialty care contribution; the company assigned the benefit from rise in contribution from new-age ingredients.

- New-age ingredients have long runway for growth. Preservatives and mild surfactants contributed 35% to specialty care and 13% total revenue for Galaxy in FY21. 1) Regulatory push and rising consumer awareness on paraben-free products (due to suspicion of paraben being carcinogenic) are driving higher demand for non-toxic preservative. Non-toxic preservative adoption has been rising in Europe due to regulatory push; but US and other developing countries may also follow soon; and 2) mild surfactants are sulphate free and have pH equal to skin. The demand for total surfactants is 10mn TPA of which SLES is ~4mn. The contribution of mild surfactants is just 5% of SLES and therefore, it has long runway for growth in next decade. We believe revenues from preservatives and mild surfactants will grow at 2x (15-18%) of Galaxy's growth in next decade.

- Gross profit/kg and EBITDA/kg will grow at CAGR of 2.3% and 6.3% over FY21-23E. Last three years' volume growth has suffered from weakness in AMET from currency depreciation in Egypt and Turkey, two key markets, and slowdown in India. We expect demand to normalise in AMET and India over the next two years on favourable base in FY21 due to Covid-19 pandemic. We are assuming volume to grow at 9% and 11% CAGR over FY21-23E in performance products and specialty care, respectively. Gross profit/kg may rise by 2.3% CAGR during the same period to Rs40.6 in FY23 (from Rs38.8 in FY21). This is in comparison to Rs40.8 in H1FY21, thus, we believe our estimates are conservative. We expect EBITDA/kg to grow at 6.3% CAGR over FY21-23E on flattish operating cost/kg, which should benefit from rise in plant utilisation.

Shares of Galaxy Surfactants Ltd was last trading in BSE at Rs.1926 as compared to the previous close of Rs. 1944.15. The total number of shares traded during the day was 2387 in over 553 trades.

The stock hit an intraday high of Rs. 1966.3 and intraday low of 1903.05. The net turnover during the day was Rs. 4600625.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Wipro - Beware of integration / impairment risks! - ICICI Securities

Easy Trip Planners Ltd - IPO Review - ICICI Direct

ICICI Direct - Derivatives Weekly View (March 5): Level of 14700 remains crucial for upsides to continue...

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020